Uzma Mehr, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 20 Elm St, Lower Level, Hornell, NY 14843 Phone: 607-590-2424 Fax: 607-590-2428 |
Tejinder S. Virdee, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 181 Seneca St, Suite 2, Hornell, NY 14843 Phone: 607-324-0660 Fax: 607-324-0770 |
News Archive
The American Gastroenterological Association Clinical Decision Tool for the Screening and Evaluation of Hepatitis C will help gastroenterologists in the early management of HCV-positive patients, according to a new paper in Gastroenterology, the official journal of the American Gastroenterological Association. Chronic HCV has a significant impact on the adult population and is a disease for which much progress has been made in its treatment.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.
Researchers at the University of Birmingham have found two biomarkers that could be used to identify a heart condition known as atrial fibrillation in patients who have three 'clinical risks'.
It is estimated that at least 1 in 5 hospitalised adults develop Acute Kidney Injury (AKI). Emerging evidence suggests that AKI: is under-recognised in clinical practice; predicts an accelerated risk of end-stage kidney disease (ESKD), and may be a risk amplifier for many other chronic diseases with death rates in excess of 20%.
› Verified 1 days ago